NBEAL2
Basic information
Region (hg38): 3:46979666-47009704
Links
Phenotypes
GenCC
Source:
- gray platelet syndrome (Supportive), mode of inheritance: AD
- gray platelet syndrome (Definitive), mode of inheritance: AR
- gray platelet syndrome (Strong), mode of inheritance: AR
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Gray platelet syndrome | AR | Hematologic | Individuals may manifest with anemia (sometimes requiring RBC transfusions) due to bleeding tendencies, and preventive measures and treatment (eg, when surgery is needed) may be beneficial; Recognition of the development of myelofibrosis may also be beneficial in order to allow prompt management | Hematologic | 5129551; 6156948; 3414674; 8192152; 20709904; 21765411; 21765412; 21765413; 23100277 |
ClinVar
This is a list of variants' phenotypes submitted to
- Gray platelet syndrome (19 variants)
- not provided (4 variants)
- NBEAL2-related disorder (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the NBEAL2 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 38 | 42 | 19 | 99 | ||
missense | 271 | 22 | 304 | |||
nonsense | 9 | |||||
start loss | 0 | |||||
frameshift | 10 | 16 | ||||
inframe indel | 7 | |||||
splice donor/acceptor (+/-2bp) | 6 | |||||
splice region | 1 | 11 | 4 | 2 | 18 | |
non coding | 25 | 20 | 51 | |||
Total | 22 | 15 | 340 | 71 | 44 |
Highest pathogenic variant AF is 0.0000131
Variants in NBEAL2
This is a list of pathogenic ClinVar variants found in the NBEAL2 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
3-46979684-G-A | Gray platelet syndrome | Uncertain significance (Jan 13, 2018) | ||
3-46979700-C-T | Gray platelet syndrome | Uncertain significance (Jan 12, 2018) | ||
3-46979742-C-G | Gray platelet syndrome | Uncertain significance (Apr 06, 2018) | ||
3-46979786-G-A | Gray platelet syndrome | Uncertain significance (Jan 13, 2018) | ||
3-46979842-G-GGCCGGA | Gray platelet syndrome | Uncertain significance (Jun 14, 2016) | ||
3-46979898-C-T | Gray platelet syndrome | Uncertain significance (Oct 09, 2023) | ||
3-46979900-C-T | Likely benign (Jun 15, 2018) | |||
3-46979923-C-T | Gray platelet syndrome | Uncertain significance (Jan 13, 2018) | ||
3-46988740-C-G | Gray platelet syndrome • NBEAL2-related disorder | Benign (Dec 31, 2019) | ||
3-46988763-G-T | NBEAL2-related disorder | Likely benign (Dec 15, 2020) | ||
3-46988849-G-A | Inborn genetic diseases | Uncertain significance (Mar 27, 2023) | ||
3-46988866-C-T | Gray platelet syndrome | Uncertain significance (Jan 13, 2018) | ||
3-46988869-G-A | Likely benign (Dec 31, 2019) | |||
3-46988888-C-T | Gray platelet syndrome • NBEAL2-related disorder | Benign (Dec 31, 2019) | ||
3-46988902-C-G | Likely benign (Jul 01, 2022) | |||
3-46988950-GC-G | Likely pathogenic (Dec 01, 2020) | |||
3-46989092-G-A | Gray platelet syndrome | Uncertain significance (Mar 30, 2018) | ||
3-46989092-G-C | Inborn genetic diseases | Uncertain significance (Jun 13, 2023) | ||
3-46989114-G-A | Inborn genetic diseases | Uncertain significance (Nov 10, 2022) | ||
3-46989154-G-C | Uncertain significance (Sep 01, 2023) | |||
3-46989276-C-G | Gray platelet syndrome | Uncertain significance (May 07, 2021) | ||
3-46989279-C-T | Inborn genetic diseases | Uncertain significance (Nov 21, 2022) | ||
3-46989287-C-T | Pathogenic (Jan 01, 2021) | |||
3-46989292-C-G | Gray platelet syndrome • NBEAL2-related disorder | Benign (Jan 13, 2018) | ||
3-46989295-G-A | NBEAL2-related disorder | Likely benign (Aug 30, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
NBEAL2 | protein_coding | protein_coding | ENST00000450053 | 54 | 30021 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.0598 | 0.940 | 124761 | 3 | 534 | 125298 | 0.00215 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 2.39 | 1385 | 1.66e+3 | 0.835 | 0.000109 | 17378 |
Missense in Polyphen | 312 | 459.62 | 0.67882 | 5098 | ||
Synonymous | 0.00237 | 706 | 706 | 1.00 | 0.0000450 | 5970 |
Loss of Function | 8.09 | 31 | 131 | 0.237 | 0.00000678 | 1390 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00708 | 0.00682 |
Ashkenazi Jewish | 0.000811 | 0.000795 |
East Asian | 0.000803 | 0.000709 |
Finnish | 0.000540 | 0.000509 |
European (Non-Finnish) | 0.000551 | 0.000529 |
Middle Eastern | 0.000803 | 0.000709 |
South Asian | 0.0105 | 0.0103 |
Other | 0.00135 | 0.00131 |
dbNSFP
Source:
- Function
- FUNCTION: Probably involved in thrombopoiesis. Plays a role in the development or secretion of alpha-granules, that contain several growth factors important for platelet biogenesis. {ECO:0000269|PubMed:21765411, ECO:0000269|PubMed:21765412}.;
- Pathway
- Neutrophil degranulation;Innate Immune System;Immune System
(Consensus)
Intolerance Scores
- loftool
- 0.763
- rvis_EVS
- -3.12
- rvis_percentile_EVS
- 0.46
Haploinsufficiency Scores
- pHI
- hipred
- Y
- hipred_score
- 0.563
- ghis
- 0.555
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.141
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | High | High | High |
Primary Immunodeficiency | High | High | High |
Cancer | High | High | High |
Mouse Genome Informatics
- Gene name
- Nbeal2
- Phenotype
- skeleton phenotype; immune system phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); neoplasm; hematopoietic system phenotype; homeostasis/metabolism phenotype; cellular phenotype;
Zebrafish Information Network
- Gene name
- nbeal2
- Affected structure
- post-vent region
- Phenotype tag
- abnormal
- Phenotype quality
- hemorrhagic
Gene ontology
- Biological process
- platelet formation;neutrophil degranulation
- Cellular component
- endoplasmic reticulum;plasma membrane;tertiary granule membrane;ficolin-1-rich granule membrane
- Molecular function
- protein binding